A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. (Q40569450)
Jump to navigation
Jump to search
scientific article published on December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. |
scientific article published on December 2002 |
Statements
1 reference
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. (English)
1 reference
Mark J Ratain
1 reference
Michael Caligiuri
1 reference
Gini F Fleming
1 reference
Neal J Meropol
1 reference
Gary L Rosner
1 reference
Donna R Hollis
1 reference
William E Carson
1 reference
Joanne Mortimer
1 reference
Katherine Tkaczuk
1 reference
Robin Parihar
1 reference
Richard L Schilsky
1 reference
1 December 2002
1 reference
1 reference